In last trading session, GlycoMimetics Inc (NASDAQ:GLYC) saw 0.52 million shares changing hands with its beta currently measuring 2.21. Company’s recent per share price level of $2.40 trading at -$0.11 or -4.19% at ring of the bell on the day assigns it a market valuation of $154.68M. That closing price of GLYC’s stock is at a discount of -47.08% from its 52-week high price of $3.53 and is indicating a premium of 53.75% from its 52-week low price of $1.11. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.59 million shares which gives us an average trading volume of 382.88K if we extend that period to 3-months.
GlycoMimetics Inc (NASDAQ:GLYC) trade information
Upright in the red during last session for losing -4.19%, in the last five days GLYC remained trading in the red while hitting it’s week-highest on Monday, 04/08/24 when the stock touched $2.40 price level, adding 14.59% to its value on the day. GlycoMimetics Inc’s shares saw a change of 1.69% in year-to-date performance and have moved -12.73% in past 5-day. GlycoMimetics Inc (NASDAQ:GLYC) showed a performance of -5.88% in past 30-days. Number of shares sold short was 1.59 million shares which calculate 4.76 days to cover the short interests.
GlycoMimetics Inc (GLYC) estimates and forecasts
Statistics highlight that GlycoMimetics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 87.50% of value to its shares in past 6 months, showing an annual growth rate of 6.90% while that of industry is 9.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 11.80% in the current quarter and calculating -7.70% decrease in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 13.11% during past 5 years.
GLYC Dividends
GlycoMimetics Inc is more likely to be releasing its next quarterly report between March 27 and April 01 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
GlycoMimetics Inc (NASDAQ:GLYC)’s Major holders
Insiders are in possession of 3.08% of company’s total shares while institution are holding 53.32 percent of that, with stock having share float percentage of 55.02%. Investors also watch the number of corporate investors in a company very closely, which is 53.32% institutions for GlycoMimetics Inc that are currently holding shares of the company. BVF Inc. is the top institutional holder at GLYC for having 9.54 million shares of worth $16.61 million. And as of Jun 29, 2023, it was holding 14.84% of the company’s outstanding shares.
The second largest institutional holder is Artal Group S.A., which was holding about 8.59 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 13.35% of outstanding shares, having a total worth of $14.94 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 1.58 million shares of worth $2.75 million or 2.46% of the total outstanding shares. The later fund manager was in possession of 0.62 million shares on Jun 29, 2023, making its stake of worth around $1.09 million in the company or a holder of 0.97% of company’s stock.
